The Global Peptide Thioester Market was valued at USD 139 Million in 2025 and is projected to reach USD 262 Million by 2034, growing at a Compound Annual Growth Rate (CAGR) of 9.6% during the forecast period (2024–2034). This robust growth is primarily driven by the escalating demand for complex biopharmaceuticals, advancements in protein engineering, and the critical role of Native Chemical Ligation (NCL) in synthesizing large, post-translationally modified proteins for therapeutic applications.

As the biopharmaceutical industry increasingly relies on sophisticated peptide synthesis for drug discovery and development, the spotlight is on the specialized manufacturers and suppliers who are pushing the boundaries of chemical biology. In this blog, we profile the Top 10 Companies in the Peptide Thioester Industry—a group of established peptide specialists and innovative CDMOs (Contract Development and Manufacturing Organizations) shaping the future of synthetic protein science.

Download FREE Sample Report:
Peptide Thioester Market – View in Detailed Research Report

---

🔟 1. Bachem Holding AG

Headquarters: Bubendorf, Switzerland
Key Offering: GMP-grade Peptide Thioesters, Custom Synthesis, API Manufacturing

Bachem is a globally recognized leader in peptide manufacturing, providing high-purity peptide thioesters for research and pharmaceutical development. The company’s expertise spans from early-stage research to commercial-scale GMP production, serving a global clientele in the biotech and pharmaceutical sectors.

Innovation & Development Initiatives:

• Investment in advanced Solid-Phase Peptide Synthesis (SPPS) technologies

• Development of novel thioesterification methodologies for complex peptides

• Strategic expansion of manufacturing capacity in Europe and the Americas

---

9️⃣ 2. PolyPeptide Group

Headquarters: Zurich, Switzerland
Key Offering: Custom Peptide Thioesters, Generic Active Peptides, Process Development

The PolyPeptide Group operates one of the world’s largest peptide manufacturing networks, with facilities across Europe, the US, and India. They are a key supplier of peptide thioesters, offering services from milligram to multi-kilogram scales for clinical and commercial applications.

Innovation & Development Initiatives:

• Focus on scalable and cost-effective thioester production processes

• R&D into environmentally friendly peptide synthesis techniques

---

8️⃣ 3. CPC Scientific, Inc.

Headquarters: Sunnyvale, California, USA
Key Offering: High-Purity Peptide Thioesters, Coupling Reagents, Specialty Amino Acids

CPC Scientific specializes in complex and custom peptides, including a wide range of thioester derivatives. The company is known for its expertise in challenging syntheses, such as long-chain peptides and those containing non-natural amino acids, which are essential for advanced NCL applications.

Innovation & Development Initiatives:

• Pioneering work in the synthesis of cyclic and constrained peptides

• Development of proprietary purification and analytical methods

---

7️⃣ 4. CSBio

Headquarters: Menlo Park, California, USA
Key Offering: Peptide Synthesizers, Custom Peptide Thioesters, GMP Services

CSBio is a unique player, being both a manufacturer of automated peptide synthesizers and a leading provider of custom peptide services, including thioesters. This dual expertise allows them to optimize synthesis protocols from an instrumentation perspective, ensuring high efficiency and yield.

Innovation & Development Initiatives:

• Integration of synthesis automation with advanced thioester generation techniques

• GMP manufacturing services for therapeutic peptide thioester candidates

Download FREE Sample Report:
Peptide Thioester Market – View in Detailed Research Report

---

6️⃣ 5. AmbioPharm, Inc.

Headquarters: North Augusta, South Carolina, USA
Key Offering: Peptide API Manufacturing, Peptide Thioesters, Process Scale-Up

AmbioPharm is a US-based CDMO with a strong focus on peptide Active Pharmaceutical Ingredients (APIs). Their services encompass the synthesis of peptide thioesters used as key intermediates in the production of complex protein-based therapeutics, including antibody-drug conjugates (ADCs).

Innovation & Development Initiatives:

• Specialization in the scale-up of complex peptide synthesis for clinical trials

• Implementation of continuous manufacturing processes for improved efficiency

---

5️⃣ 6. CordenPharma

Headquarters: Plankstadt, Germany
Key Offering: Lipidated Peptides, Peptide Thioesters, GMP Manufacturing

CordenPharma is a major international CDMO with dedicated peptide facilities. They offer comprehensive services for peptide thioesters, particularly for challenging molecules like lipopeptides and long-chain sequences that are difficult to produce using standard biological methods.

Innovation & Development Initiatives:

• Investment in state-of-the-art chromatography and lyophilization capabilities

• Focus on sustainability through solvent recycling and green chemistry principles

---

4️⃣ 7. Almac Group

Headquarters: Craigavon, United Kingdom
Key Offering: Peptide & Biologics Services, Peptide Thioesters, Analytical Support

The Almac Group provides integrated drug development services, including the synthesis of advanced peptide intermediates like thioesters. Their expertise supports clients from discovery through to commercial supply, with a strong regulatory and analytical foundation.

Innovation & Development Initiatives:

• Development of novel linker technologies for NCL applications

• Comprehensive analytical method development and validation services

---

3️⃣ 8. Lonza

Headquarters: Basel, Switzerland
Key Offering: Custom Peptides, Peptide Thioesters, Large-Scale API Manufacturing

While Lonza is a giant in biologics manufacturing, its peptide division is a significant contributor to the thioester market. They leverage their extensive experience in process development and GMP compliance to deliver high-quality peptide thioesters for critical therapeutic programs.

Innovation & Development Initiatives:

• Application of cutting-edge peptide synthesis platforms to thioester production

• Strategic partnerships with biotech firms for co-development of novel therapeutics

---

2️⃣ 9. WuXi AppTec

Headquarters: Shanghai, China
Key Offering: Integrated R&D Services, Peptide Thioesters, Process Chemistry

WuXi AppTec is a global leader in pharmaceutical R&D and manufacturing services. Their chemistry services division has strong capabilities in peptide synthesis, including the production of thioesters for clients worldwide, supported by a large team of scientists and extensive infrastructure.

Innovation & Development Initiatives:

• Rapid process development and optimization for cost-effective manufacturing

• Expansion of high-potency API (HPAPI) capabilities for targeted therapeutics

---

1️⃣ 10. ScinoPharm Taiwan, Ltd.

Headquarters: Tainan, Taiwan
Key Offering: Generic and Custom APIs, Peptide Thioesters, Advanced Intermediates

ScinoPharm is a leading API manufacturer in Asia with growing expertise in peptide chemistry. They provide peptide thioesters as critical building blocks for both internal development programs and custom synthesis projects for international clients, benefiting from competitive cost structures.

Innovation & Development Initiatives:

• Focus on developing efficient synthetic routes for complex peptide structures

• Investment in new facilities to increase peptide manufacturing capacity

Get Full Report Here:
Peptide Thioester Market – View in Detailed Research Report

---

🧪 Outlook: The Future of Peptide Thioesters Is More Efficient and Accessible

The peptide thioester market is undergoing a significant transformation. While traditional synthetic methods remain foundational, the industry is heavily investing in novel ligation strategies, automation, and scalable manufacturing processes to meet the growing demands of biopharmaceutical R&D.

📈 Key Trends Shaping the Market:

• Accelerated adoption of one-pot ligation and desulfurization strategies to simplify protein synthesis

• Growing demand for peptide thioesters in the development of next-generation therapeutics, including cyclic peptides and protein degraders (PROTACs)

• Increased outsourcing of complex peptide synthesis to specialized CDMOs to manage risk and cost

• Regulatory emphasis on robust and well-characterized synthetic processes for peptide-based drugs

Get Full Report Here:
Peptide Thioester Market – View in Detailed Research Report

The companies listed above are not only supplying critical building blocks for modern science—they are actively driving innovation in synthetic chemistry to enable the creation of tomorrow’s life-saving medicines.